Vivek Garipalli

Insider Reports History

Reporting-owner location: Franklin, TN
Latest reporting-owner signature: /s/Peter J. Rivas as attorney-in-fact for Vivek Garipalli
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Vivek Garipalli

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 75,694,143
Estimated value: $272,498,915
Report date: 07 Jan 2025
Price: $3.60
Ownership: Held by NJ Healthcare Investment, LLC
Underlying class: Class A Common Stock
Underlying amount: 75,694,143

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 72,084,543
Estimated value: $178,048,821
Report date: 07 Jan 2026
Price: $2.47
Ownership: Held by NJ Healthcare Investments, LLC
Underlying class: Class A Common Stock
Underlying amount: 75,694,143

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 11,500,000
Estimated value: $28,405,000
Report date: 07 Jan 2026
Price: $2.47
Ownership: Held by Ceasar Clover, LLC
Underlying class: Class A Common Stock
Underlying amount: 12,075,857

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 8,591,093
Estimated value: $21,219,999
Report date: 07 Jan 2026
Price: $2.47
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 9,021,288

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 5,645,934
Estimated value: $20,325,362
Report date: 07 Jan 2025
Price: $3.60
Ownership: Held by Ceasar Ventures, LLC
Underlying class: Class A Common Stock
Underlying amount: 5,645,934

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class A Common Stock
Shares / value: 1,856,247
Estimated value: $4,807,679
Report date: 07 Jan 2026
Price: $2.59
Ownership: Direct

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Class B Common Stock
Shares / value: 182,201
Estimated value: $655,924
Report date: 07 Jan 2025
Price: $3.60
Ownership: Held by Titus Ventures, LLC
Underlying class: Class A Common Stock
Underlying amount: 182,201

Form 4 holding Director, 10%+ Owner

CLOVER HEALTH INVESTMENTS, CORP. /DE

Security class: Restricted Stock Unit
Shares / value: 0
Estimated value
Report date: 07 Jan 2026
Price
Ownership: Direct
Underlying class: Class B Common Stock
Underlying amount

Insider Reports Filed by Vivek Garipalli

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Jan 2026
Transactions: 5
Transaction value: -$4,288,908
Accepted by SEC: 09 Jan 2026, 16:08
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Aug 2025
Transactions: 2
Transaction value: +$998,997
Accepted by SEC: 08 Aug 2025, 16:07
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Jan 2025
Transactions: 5
Transaction value: -$6,015,474
Accepted by SEC: 10 Jan 2025, 16:34
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 09 Aug 2024
Transactions: 1
Transaction value: +$999,596
Accepted by SEC: 13 Aug 2024, 16:06
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 17 Jun 2024
Transactions: 1
Transaction value: +$1,000,426
Accepted by SEC: 20 Jun 2024, 16:03
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Jan 2024
Transactions: 5
Transaction value: -$1,483,012
Accepted by SEC: 09 Jan 2024, 16:05
Role: Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Jan 2023
Transactions: 5
Transaction value: -$1,585,290
Accepted by SEC: 28 Apr 2023, 20:23
Role: Executive Chairperson, Director, 10%+ Owner
Next action: Open filing details

4 CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Report period: 07 Jan 2022
Transactions: 3
Transaction value: -$5,260,847
Accepted by SEC: 11 Jan 2022, 20:51
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Vivek Garipalli

Insider Reports Filed by Vivek Garipalli